Network of the comparisons and comparative efficacy and tolerance results. (A) Network plot of all treatment groups evaluated in the NMA for PFS. The number of studies that analyzed each treatment group is shown inside the circles; the overall numbers of patients included in the analysis for each group are provided in parentheses. (B) Effect estimates of the treatment in terms of PFS (column headings being compared with row headings) and safety (row headings being compared with column headings). PFS is reported as HR and safety is reported as RR (95% credible intervals are in parentheses). Statistically significant comparisons are shown in bold. DEX, dexamethasone.